24,109 Shares in The Pennant Group, Inc. $PNTG Purchased by Counterpoint Mutual Funds LLC

Counterpoint Mutual Funds LLC acquired a new stake in shares of The Pennant Group, Inc. (NASDAQ:PNTG) during the 3rd quarter, according to its most recent Form 13F filing with the Securities and Exchange Commission (SEC). The firm acquired 24,109 shares of the company’s stock, valued at approximately $940,000.

A number of other large investors also recently bought and sold shares of PNTG. BlackRock Inc. purchased a new stake in The Pennant Group during the second quarter worth $109,340,000. Wasatch Advisors LP boosted its position in The Pennant Group by 31.8% during the 2nd quarter. Wasatch Advisors LP now owns 1,870,178 shares of the company’s stock valued at $69,103,000 after acquiring an additional 451,491 shares in the last quarter. Turtle Creek Asset Management Inc. boosted its position in The Pennant Group by 12,075.6% during the 1st quarter. Turtle Creek Asset Management Inc. now owns 1,582,823 shares of the company’s stock valued at $48,244,000 after acquiring an additional 1,569,823 shares in the last quarter. Paradigm Capital Management Inc. NY purchased a new position in shares of The Pennant Group in the 2nd quarter valued at $51,833,000. Finally, Dimensional Fund Advisors LP increased its holdings in shares of The Pennant Group by 1.5% in the 1st quarter. Dimensional Fund Advisors LP now owns 815,660 shares of the company’s stock valued at $24,861,000 after acquiring an additional 11,943 shares during the period. Institutional investors own 85.88% of the company’s stock.

Wall Street Analyst Weigh In

PNTG has been the subject of several recent research reports. Weiss Ratings raised The Pennant Group from a “buy (b-)” rating to a “buy (b)” rating in a research report on Wednesday, August 19th. Truist Financial upped their price objective on The Pennant Group from $42.00 to $48.00 and gave the stock a “buy” rating in a research note on Tuesday, July 14th. Royal Bank Of Canada raised their price objective on The Pennant Group from $42.00 to $44.00 and gave the company an “outperform” rating in a research report on Thursday, August 20th. Wells Fargo & Company raised their price objective on The Pennant Group from $45.00 to $46.00 and gave the company an “overweight” rating in a research report on Tuesday, August 11th. Finally, Wall Street Zen upgraded The Pennant Group from a “hold” rating to a “buy” rating in a research note on Saturday, June 20th. Six investment analysts have rated the stock with a Buy rating and one has given a Hold rating to the company’s stock. Based on data from MarketBeat, The Pennant Group has a consensus rating of “Moderate Buy” and a consensus price target of $42.00.

The Pennant Group Trading Down 0.9%

NASDAQ PNTG opened at $41.87 on Friday. The company has a quick ratio of 1.20, a current ratio of 1.20 and a debt-to-equity ratio of 0.48. The firm has a market cap of $1.46 billion, a PE ratio of 46.52, a price-to-earnings-growth ratio of 2.73 and a beta of 1.25. The company has a 50 day moving average price of $39.38 and a 200 day moving average price of $36.45. The Pennant Group, Inc. has a 52 week low of $22.25 and a 52 week high of $42.74.

The Pennant Group (NASDAQ:PNTG) last posted its earnings results on Wednesday, August 5th. The company reported $0.36 EPS for the quarter, beating analysts’ consensus estimates of $0.33 by $0.03. The company had revenue of $297.98 million during the quarter, compared to analysts’ expectations of $288.71 million. The Pennant Group had a net margin of 2.93% and a return on equity of 10.33%. The Pennant Group has set its FY 2026 guidance at 1.340-1.410 EPS. As a group, sell-side analysts forecast that The Pennant Group, Inc. will post 1.18 EPS for the current fiscal year.

The Pennant Group Profile

The Pennant Group, Inc (NASDAQ:PNTG) is a healthcare services company that operates businesses focused on home-based care and senior living. Through its affiliated companies, Pennant provides home health, hospice and personal care services, as well as residential senior living services for older adults with varying care needs.

Its home health operations offer clinical care and rehabilitation services in patients’ homes, while its hospice businesses provide comfort-focused care and support for individuals with advanced illnesses and their families.